NCT06039436View on ClinicalTrials.gov

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

RecruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

May 31, 2025

Conditions
Severe Aplastic Anemia
Interventions
DRUG

Anti-Thymocyte Globulin (Rabbit)

Indications for trial stopping: subjects occur pregnancy events, severe organ function impairments, or emergency events related or unrelated to treatment; or subjects are unwilling to continue participating in the clinical trial.

Trial Locations (1)

230036

RECRUITING

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV